Nuclear Receptor Corepressor 1 expression and output declines with prostate cancer progression

PURPOSE: Castration therapy in advanced prostate cancer eventually fails and leads to development of castration resistant prostate cancer (CRPC) which has no cure. Characteristic features of CRPC can be increased androgen receptor (AR) expression and altered transcriptional output. We investigated e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Lopez, Sandra M., Agoulnik, Alexander I., Zhang, Manqi, Peterson, Leif E., Suarez, Egla, Gandarillas, Gregory A., Frolov, Anna, Li, Rile, Rajapakshe, Kimal, Coarfa, Christian, Ittmann, Michael M., Weigel, Nancy L., Agoulnik, Irina U.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4970919/
https://ncbi.nlm.nih.gov/pubmed/26968201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-1983
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados